Volume 30, Issue 2 supplement | Neurological Sciences

Search all Neurological Sciences articles

Volume 30, Issue 2 supplement

October 2009

Second line treatments for multiple sclerosis: benefits and risks

Filter by

Volume:

Sort by

Date published:

New to old Old to new

7 articles in this issue

Treatment of multiple sclerosis: role of natalizumab
Giancarlo Comi
MS Treatment 01 November 2009 Pages: 155 - 158
Safety profile of Tysabri: international risk management plan
P. Iaffaldano
M. D’Onghia
Maria Trojano
MS Treatment 01 November 2009 Pages: 159 - 162
The pharmacovigilance program on natalizumab in Italy: 2 years of experience
G. Tedeschi
M. P. Amato
G. L. Mancardi
MS Treatment 01 November 2009 Pages: 163 - 165
Mitoxantrone: benefits and risks in multiple sclerosis patients
V. Martinelli
M. Radaelli
G. Comi
MS Treatment 01 November 2009 Pages: 167 - 170
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks
Luciano Rinaldi
P. Perini
P. Gallo
MS Treatment 01 November 2009 Pages: 171 - 173
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks
E. Capello
L. Vuolo
Gianluigi Mancardi
MS Treatment 01 November 2009 Pages: 175 - 177
New oral drugs for multiple sclerosis
Claudio Gasperini
S. Ruggieri
MS Treatment 01 November 2009 Pages: 179 - 183